Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mercator MedicalFRA:MM2 +1.07%62 EV-to-EBIT is 14.21 as of Jul. 25, 2026, which is 105% above its 10-year median of 6.92. GuruFocus rates FRA:MM2 with a GF Score™ of 62/100 and a GF Value™ of €11.73 (Fairly Valued). The stock has 2 warning signs investors should review. Among 465 Medical Devices & Instruments companies, Mercator Medical ranks better than 59.78% on this metric.
The historical rank and industry rank for Mercator Medical's EV-to-EBIT or its related term are showing as below:
FRA:MM2'
s EV-to-EBIT Range Over the Past 10 Years
Min: -142.82 Med: 6.92 Max: 42.69
Current: 14.08
During the past 13 years, the highest EV-to-EBIT of Mercator Medical was 42.69. The lowest was -142.82. And the median was 6.92.
FRA:MM2's EV-to-EBIT is ranked better than 59.78% of 465
companies
in the Medical Devices & Instruments industry
Industry Median: 18.19
vs FRA:MM2: 14.08
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Mercator Medical's Enterprise Value for the quarter that ended in Mar. 2026 was €54.5 Mil.
Mercator Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercator Medical EV-to-EBIT Related Terms
Mercator Medical EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Mercator Medical's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Mercator Medical's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercator Medical EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Mercator Medical's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Mercator Medical's EV-to-EBIT falls into.
Mercator Medical's current Enterprise Value is €63.1 Mil.
Mercator Medical's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercator Medical (FRA:MM2) has a EV-to-EBIT of 14.21 as of Jul. 25, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mercator Medical and its competitors. This is 105% above median its historical median of 6.92. According to the industry distribution chart, Mercator Medical ranks #187 out of 465 companies in the Medical Devices & Instruments industry, placing it in the top 40.2%.
Is Mercator Medical's EV-to-EBIT too high?
Mercator Medical's current EV-to-EBIT of 14.21 is 105% above median its 10-year median of 6.92. The Medical Devices & Instruments industry median EV-to-EBIT is 18.19. Mercator Medical's value of 14.21 is 21.9% below this industry median. Based on the distribution chart, Mercator Medical ranks #187 out of 465 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Mercator Medical has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercator Medical's EV-to-EBIT compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Mercator Medical ranks #187 out of 465 companies for EV-to-EBIT. This puts Mercator Medical in the upper half of its industry. The industry median EV-to-EBIT is 18.19. Mercator Medical's value of 14.21 is 21.9% below this benchmark. While the company's 10-year median is 6.92 vs. the industry median of 18.19, Mercator Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Devices & Instruments company?
The median EV-to-EBIT among Medical Devices & Instruments companies is 18.19, based on 465 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercator Medical's current EV-to-EBIT of 14.21 is 21.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Mercator Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-EBIT is 18.19 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercator Medical's current EV-to-EBIT is 14.21, which is 105% above median its own 10-year median of 6.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercator Medical stock overvalued right now?
Based on GuruFocus' analysis, Mercator Medical (FRA:MM2) is currently considered Fairly Valued. The stock's GF Value™ is €11.73, compared to a current price of €11.32 — trading 3.5% below its estimated fair value. The current EV-to-EBIT is 14.21, which is 105% above median its 10-year median of 6.92 and 21.9% below the Medical Devices & Instruments industry median of 18.19. Mercator Medical's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Mercator Medical (FRA:MM2), the current EV-to-EBIT is 14.21 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercator Medical (FRA:MM2) Overvalued in 2026?
Based on GuruFocus' analysis, Mercator Medical stock appears to be undervalued.
The current stock price of €11.32 is trading 3.5% below its estimated GF Value™ of €11.73.
GuruFocus considers Mercator Medical to be Fairly Valued.
Key valuation signals for FRA:MM2:
EV-to-EBIT: 14.21 (105% above median its 10-year median of 6.92)
GF Value™: €11.73 vs. price of €11.32 (3.5% below fair value)
Industry Position: 21.9% below the Medical Devices & Instruments median (#187 of 465)
No single metric tells the full story. See the FRA:MM2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercator Medical SA produces and sells medical gloves and distributor of medical disposables. The company's products - mainly gloves, dressings, disposable clothing and surgical drapes. It operates in Europe and Russia.
62GF Score
Get the complete analysis for FRA:MM2
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MM2 has been successfully added to your 
